Literature DB >> 12438326

Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen.

Bo Wei1, Tiffany Huang, Harnisha Dalwadi, Christopher L Sutton, David Bruckner, Jonathan Braun.   

Abstract

Commensal bacteria have emerged as an important disease factor in human Crohn's disease (CD) and murine inflammatory bowel disease (IBD) models. We recently isolated I2, a novel gene segment of microbial origin that is associated with human CD and that encodes a T-cell superantigen. To identify the I2 microorganism, BLAST analysis was used to identify a microbial homologue, PA2885, a novel open reading frame (ORF) in the Pseudomonas aeruginosa genome. PCR and Southern analysis identified Pseudomonas fluorescens as the originating species of I2, with homologues detectable in 3 of 13 other Pseudomonas species. Genomic cloning disclosed a locus containing the full-length I2 gene (pfiT) and three other orthologous genes, including a homologue of the pbrA/pvdS iron response gene. CD4(+) T-cell responses to recombinant proteins were potent for I2 and pfiT, but modest for PA2885. pfiT has several features of a virulence factor: association with an iron-response locus, restricted species distribution, and T-cell superantigen bioactivity. These findings suggest roles for pfiT and P. fluorescens in the pathogenesis of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438326      PMCID: PMC133002          DOI: 10.1128/IAI.70.12.6567-6575.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs.

Authors:  J K Ichikawa; A Norris; M G Bangera; G K Geiss; A B van 't Wout; R E Bumgarner; S Lory
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

Authors:  J Abe; M Onimaru; S Matsumoto; S Noma; K Baba; Y Ito; T Kohsaka; T Takeda
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

3.  Selected bacterial antibodies in Crohn's disease and ulcerative colitis.

Authors:  I O Auer; A Röder; F Wensinck; J P van de Merwe; H Schmidt
Journal:  Scand J Gastroenterol       Date:  1983-03       Impact factor: 2.423

4.  Serum antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease.

Authors:  K Suenaga; Y Yokoyama; I Nishimori; S Sano; M Morita; K Okazaki; S Onishi
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

5.  Memory/effector T cells in TCR transgenic mice develop via recognition of enteric antigens by a second, endogenous TCR.

Authors:  A Saparov; L A Kraus; Y Cong; J Marwill; X Y Xu; C O Elson; C T Weaver
Journal:  Int Immunol       Date:  1999-08       Impact factor: 4.823

6.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

7.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.

Authors:  C K Stover; X Q Pham; A L Erwin; S D Mizoguchi; P Warrener; M J Hickey; F S Brinkman; W O Hufnagle; D J Kowalik; M Lagrou; R L Garber; L Goltry; E Tolentino; S Westbrock-Wadman; Y Yuan; L L Brody; S N Coulter; K R Folger; A Kas; K Larbig; R Lim; K Smith; D Spencer; G K Wong; Z Wu; I T Paulsen; J Reizer; M H Saier; R E Hancock; S Lory; M V Olson
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

Review 8.  T-cell transfer and cytokine/TCR gene deletion models in the study of inflammatory bowel disease.

Authors:  S Bregenholt; D Delbro; M H Claesson
Journal:  APMIS       Date:  1997-09       Impact factor: 3.205

9.  The oxygen- and iron-dependent sigma factor pvdS of Pseudomonas aeruginosa is an important virulence factor in experimental infective endocarditis.

Authors:  Y Q Xiong; M L Vasil; Z Johnson; U A Ochsner; A S Bayer
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

10.  Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.

Authors:  H C Rath; M Schultz; R Freitag; L A Dieleman; F Li; H J Linde; J Schölmerich; R B Sartor
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

View more
  44 in total

Review 1.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

Review 2.  Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease.

Authors:  Anet A Soubières; Andrew Poullis
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 3.  Crohn's disease and infections: a complex relationship.

Authors:  Gert De Hertogh; Karel Geboes
Journal:  MedGenMed       Date:  2004-08-10

4.  Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis.

Authors:  S Joossens; J-F Colombel; C Landers; D Poulain; K Geboes; X Bossuyt; S Targan; P Rutgeerts; W Reinisch
Journal:  Gut       Date:  2006-05-10       Impact factor: 23.059

5.  Possible diagnostic role of antibodies to Crohn's disease peptide (ACP): results of a multicenter study in a Japanese cohort.

Authors:  Keiichi Mitsuyama; Mikio Niwa; Junya Masuda; Hiroshi Yamasaki; Kotaro Kuwaki; Hidetoshi Takedatsu; Teppei Kobayashi; Fukunori Kinjo; Kazuto Kishimoto; Toshiyuki Matsui; Fumihito Hirai; Kazuya Makiyama; Kazuo Ohba; Hiroo Abe; Hirohito Tsubouchi; Hiroshi Fujita; Ryuichiro Maekawa; Hiroshi Yoshida; Michio Sata
Journal:  J Gastroenterol       Date:  2013-12-03       Impact factor: 7.527

6.  Isolation and characterization of a novel short peptide associated with Crohn's disease.

Authors:  K Mitsuyama; M Niwa; J Masuda; K Kuwaki; H Yamasaki; H Takedatsu; T Kobayashi; M Sata
Journal:  Clin Exp Immunol       Date:  2011-07-28       Impact factor: 4.330

Review 7.  Biomarkers in inflammatory bowel disease: current practices and recent advances.

Authors:  Heba N Iskandar; Matthew A Ciorba
Journal:  Transl Res       Date:  2012-02-01       Impact factor: 7.012

8.  RahU: an inducible and functionally pleiotropic protein in Pseudomonas aeruginosa modulates innate immunity and inflammation in host cells.

Authors:  Jayasimha Rao; Michael R Elliott; Norbert Leitinger; Roderick V Jensen; Joanna B Goldberg; Ashok R Amin
Journal:  Cell Immunol       Date:  2011-05-24       Impact factor: 4.868

9.  Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?

Authors:  Christelle Basset; John Holton; Alexandra Bazeos; Dino Vaira; Stuart Bloom
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

10.  The clinical Pseudomonas fluorescens MFN1032 strain exerts a cytotoxic effect on epithelial intestinal cells and induces Interleukin-8 via the AP-1 signaling pathway.

Authors:  Amar Madi; Omar Lakhdari; Hervé M Blottière; Muriel Guyard-Nicodème; Karine Le Roux; Anne Groboillot; Pascal Svinareff; Joel Doré; Nicole Orange; Marc G J Feuilloley; Nathalie Connil
Journal:  BMC Microbiol       Date:  2010-08-10       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.